Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-08-20

FDA Approved: HYDROCHLOROTHIAZIDE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for Hydrochlorothiazide from Aurobindo Pharma Limited. The decision updates the approved generic product and allows cont…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HYDROCHLOROTHIAZIDE (hydrochlorothiazide)

Snippet

SUPPL AP for HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE)